Mice receiving hydrogel-delivered vesicles had more regulatory T cells in their lymph nodes and retained more ...
Age-related changes in the brain’s body clock are linked to early symptoms of the disease, providing new targets for research ...
Multifaceted approach connects genetic variants to effector genes and gene programs, downstream cellular phenotypes and ...
Targeting FOLR1 with an approved antibody-drug conjugate restored anti-tumor immunity and enhanced anti-PD-1 effectiveness in ...
Flagship Pioneering has launched its first dedicated company creation unit outside of the U.S. with an initial commitment of ...
A recent partnership to automate manufacturing for engineered TILs focuses on standardization to enhance consistency.
Company highlights production processes and quality control strategies for consistent and compliant extracellular vesicle ...
Rapid sterility testing methods run in parallel are a better option for checking that cell therapies are free of bacterial ...
The timing reflects where the industry is heading. Companies are shifting more of their portfolios to biologics, and production is spreading across more internal and contract sites. “Supply chain ...
Alcohol cut anti-PD-1 efficacy by about 50% in mice, suppressing some T cells and boosting TIGIT-expressing ones.
ImmunoBrain has generated early-stage clinical data showing success for a first-of-its-kind, immunotherapy-based approach to ...
Findings provide framework for optimizing experimental models, improving transplantation strategies and informing HSC-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results